| Date Filed | Type | Description |
| 07/03/2023 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on PROKIDNEY CORP.|
Txns:
| Granted 48,128 options to buy
@ $10.56, valued at
$508.2k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 837 shares
@ $69.659, valued at
$58.3k
|
|
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 995 shares
@ $149.378, valued at
$148.6k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
3
| DOYLE WILLIAM F (Director) has filed a Form 3 on Elanco Animal Health Inc |
| 08/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.4, valued at
$136k
|
|
| 06/12/2020 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on OptiNose, Inc.|
Txns:
| Granted 14,439 options to buy
@ $5.65, valued at
$81.6k
|
|
| 05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2020 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 133,777 shares
@ $95, valued at
$12.7M
|
|
| 11/26/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 16,223 shares
@ $96.04, valued at
$1.6M
|
|
| 11/22/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 149,300 shares
@ $90.3551, valued at
$13.5M
Sold 700 shares
@ $91.01, valued at
$63.7k
|
|
| 11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Bought 3,500 shares
@ $5.5, valued at
$19.3k
|
|
| 06/13/2019 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.5, valued at
$90k
|
|
| 06/10/2019 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on OptiNose, Inc.|
Txns:
| Granted 14,439 options to buy
@ $6.6, valued at
$95.3k
|
|
| 06/03/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 48,100 shares
@ $53.067, valued at
$2.6M
|
|
| 05/31/2019 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.21, valued at
$104.2k
|
|
| 05/31/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 1,900 shares
@ $53.095, valued at
$100.9k
|
|
|